Sa1710 Long-Term Outcomes After Single Balloon Enteroscopy in Patients With Obscure Gastrointestinal Bleeding

      The small bowel (SB) is the most common source of blood loss in patients with obscure gastrointestinal bleeding (OGIB). Without specific therapy 60-75% of patients with OGIB experience continued GI blood loss. The rate of recurrent OGIB after double balloon enteroscopy (DBE) has been reported to be 40% at 30 months of follow up. The impact of single balloon enteroscopy (SBE) on the long-term outcomes of patients with OGIB has not been established.
      To read this article in full you will need to make a payment


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect